Author: BusinessWire

March 18, 2021 Off

VIB4920 by Viela Bio: A Fusion Protein Designed to Bind to CD40L on Activated T-Cells, Blocking Their Interaction with CD40-expressing B Cells – Global Emerging Insight and Market Forecast 2021-2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “VIB4920 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

VIB4920, is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction wi…